Pfizer to start testing of COVID-19 vaccine in children below 12

0
83

Pfizer Inc said it would start a large study to test its COVID-19 vaccine in children below 12 and selected a dosing regime for the trial. The vaccine has been authorized for use in children as young as 12 in Europe, the United States, and Canada.

LEAVE A REPLY

Please enter your comment!
Please enter your name here